[83] List et al. (2009) T2DM drug-naive patients (n = 389 ... co-transporters located at the brush border of tubular cells (SGLT2 and SGLT1) and the GLUTs facilitated diffusion glucose ...

One study published in December 2022 found that semaglutide lowered the risk of dementia in patients with type 2 diabetes.

A new study found a link between SGLT-2 inhibitors and a significantly lower risk of dementia in people with diabetes. Here's ...

Merck and Pfizer are to take on the crowded SGLT2 ... day at list price. The US approval has achieved, the companies await similar clearance in Europe, the other leading market for the drugs.

Mineralys has been on the radar for some biotech investors. Read more about MLYS' hypertension treatment, upcoming trial ...

These two failures combined to undermine Wall Street's confidence in Filspari - a drug analysts had previously ... be used safely in combination with SGLT2 inhibitors. While Travere's CMO is ...

Holding anticoagulation and diabetic medications (particularly GLP-1 agonists and SGLT2 inhibitors) should follow a standard ... All other trademarks are property of their respective owners. For a ...

Tirzepatide, a novel GLP-1/GIP dual receptor agonist, shows significant advantages in glycemic management and weight control. By summarizing the results of the SURMOUNT and SURPASS clinical trials, we ...

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of diabetes drugs also known as gliflozins, could lower the risk ...